Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, L., Vitamin-based Asthma Therapeutics: 1α,25-dihydroxyvitamin D(3) inhibits asthma pathogenesis via down regulation of its target gene, 21/August/2014, 05.53 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org.
*Research cooperation
Significance: This study suggests that 1α,25-dihydroxyvitamin D(3), by suppressing the expression of its target gene, it may up regulate the expression of a gene that is required to inhibit asthma pathogenesis. Together, this study suggests that pharmacological formulations encompassing “1α,25-dihydroxyvitamin D(3) or its analogues” may be used to treat patients suffering from severe asthma.
